- Active not recruitingPHASE1
Study of E7386 in Participants With Selected Advanced Neoplasms
This study is testing a new medicine, E7386, for people with certain advanced cancers. Researchers want to see if it's safe, what side effects it might cause, and find the best dose to use in future studies. It's an early-stage trial.
For: Advanced NeoplasmsUnited States · United Kingdom - Active not recruitingPHASE1, PHASE2
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
This study is testing a new drug, E7386, alongside other cancer medicines. It aims to find the safest and most effective dose for people with various solid tumours, especially endometrial cancer, and to understand how these combinations work.
For: Endometrial Neoplasms · Neoplasms · Carcinoma, HepatocellularUnited States · Canada · China